Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT07629401
Clinical Trial
Provide Pre-approval Expanded Access of LY3437943
Available
View on ClinicalTrials.gov →
Summary
Provide pre-approval single patient expanded access of retatrutide for patients.
Trial Details
NCT Number
NCT07629401
Lead Sponsor
Eli Lilly and Company
Updated on ClinicalTrials.gov
2026-06-05